{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:22:47Z","timestamp":1719966167296},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,2]]},"DOI":"10.7759\/cureus.63676","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T15:48:56Z","timestamp":1719935336000},"source":"Crossref","is-referenced-by-count":0,"title":["Heparin-Induced Hemorrhagic Bullous Dermatosis: A Rare Complication of Unfractionated Heparin"],"prefix":"10.7759","author":[{"given":"Rida","family":"Zakar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nader","family":"Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"El Tannoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boutros","family":"El Tannoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Ali","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moussa","family":"Riachy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lamisse","family":"Karam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2011.06.012","article-title":"Bullous hemorrhagic dermatosis at distant sites: a report of 2 new cases due to enoxaparin injection and a review of the literature","volume":"103","author":"Villanueva CA","year":"2012","unstructured":"Villanueva CA, N\u00e1jera L, Espinosa P, Borbujo J. Bullous hemorrhagic dermatosis at distant sites: a report of 2 new cases due to enoxaparin injection and a review of the literature. Actas Dermosifiliogr. 2012, 103:816-9. 10.1016\/j.ad.2011.06.012","journal-title":"Actas Dermosifiliogr"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2020.06.044","article-title":"Heparin-induced bullous hemorrhagic dermatosis: a report of 3 cases","volume":"6","author":"Frizzell MR","year":"2020","unstructured":"Frizzell MR, Nguyen NM, Goldberg LH, Parikh SA, Sinai MJ. Heparin-induced bullous hemorrhagic dermatosis: a report of 3 cases. JAAD Case Rep. 2020, 6:1065-8. 10.1016\/j.jdcr.2020.06.044","journal-title":"JAAD Case Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/jpgm.jpgm_282_22","article-title":"Bullous hemorrhagic dermatosis: a rare cutaneous reaction of heparin","volume":"69","author":"Dhattarwal N","year":"2023","unstructured":"Dhattarwal N, Gurjar R. Bullous hemorrhagic dermatosis: a rare cutaneous reaction of heparin. J Postgrad Med. 2023, 69:97-8. 10.4103\/jpgm.jpgm_282_22","journal-title":"J Postgrad Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2021.05.003","article-title":"Bullous haemorrhagic dermatitis induced by heparins and other anticoagulants: 94 cases from French pharmacovigilance centres and a literature review","volume":"149","author":"Uceda-Martin M","year":"2022","unstructured":"Uceda-Martin M, Lambert A, Miremont G, et al.. Bullous haemorrhagic dermatitis induced by heparins and other anticoagulants: 94 cases from French pharmacovigilance centres and a literature review. Ann Dermatol Venereol. 2022, 149:45-50. 10.1016\/j.annder.2021.05.003","journal-title":"Ann Dermatol Venereol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2008.10.037","article-title":"Low-molecular-weight heparin-induced bullous haemorrhagic dermatosis associated with cell-mediated hypersensitivity [Article in French]","volume":"136","author":"Thuillier D","year":"2009","unstructured":"Thuillier D, Chaby G, Dadban A, et al.. Low-molecular-weight heparin-induced bullous haemorrhagic dermatosis associated with cell-mediated hypersensitivity [Article in French]. Ann Dermatol Venereol. 2009, 136:705-8. 10.1016\/j.annder.2008.10.037","journal-title":"Ann Dermatol Venereol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-018-0108-7","article-title":"Bullous hemorrhagic dermatosis is an under-recognized side effect of full dose low-molecular weight heparin: a case report and review of the literature","volume":"7","author":"Russo A","year":"2018","unstructured":"Russo A, Curtis S, Balbuena-Merle R, Wadia R, Wong E, Chao HH. Bullous hemorrhagic dermatosis is an under-recognized side effect of full dose low-molecular weight heparin: a case report and review of the literature. Exp Hematol Oncol. 2018, 7:15. 10.1186\/s40164-018-0108-7","journal-title":"Exp Hematol Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/21548331.2016.1159908","article-title":"Hemorrhagic bullous dermatosis: a rare heparin-induced cutaneous manifestation","author":"Govind B","year":"2016","unstructured":"Govind B, Gnass E, Merli G, Eraso L. Hemorrhagic bullous dermatosis: a rare heparin-induced cutaneous manifestation. 2016. 10.1080\/21548331.2016.1159908"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13159","article-title":"Enoxaparin-induced bullous haemorrhagic dermatosis","volume":"61","author":"Lobo Y","year":"2020","unstructured":"Lobo Y, Robertson I, Stewart A, Rowe C. Enoxaparin-induced bullous haemorrhagic dermatosis. Australas J Dermatol. 2020, 61:e124-5. 10.1111\/ajd.13159","journal-title":"Australas J Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20165418","article-title":"Heparin induced bullous hemorrhagic dermatosis at a site distant from the injection. A report of five cases","author":"Gargallo V","year":"2016","unstructured":"Gargallo V, Romero FT, Rodr\u00edguez-Peralto JL, Zarco C. Heparin induced bullous hemorrhagic dermatosis at a site distant from the injection. A report of five cases. 2016. 10.1590\/abd1806-4841.20165418"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0000000000001787","article-title":"Heparin-induced bullous hemorrhagic dermatosis: a report of an exceptionally exuberant case and literature review","volume":"43","author":"Cortez de Almeida RF","year":"2021","unstructured":"Cortez de Almeida RF, Vita Campos C, Daxbacher EL, Jeunon T. Heparin-induced bullous hemorrhagic dermatosis: a report of an exceptionally exuberant case and literature review. Am J Dermatopathol. 2021, 43:497-505. 10.1097\/DAD.0000000000001787","journal-title":"Am J Dermatopathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ramb.2012.11.004","article-title":"Heparin-induced thrombocytopenia: a review of concepts regarding a dangerous adverse drug reaction","volume":"59","author":"Junqueira DR","year":"2013","unstructured":"Junqueira DR, Carvalho Md, Perini E. Heparin-induced thrombocytopenia: a review of concepts regarding a dangerous adverse drug reaction. Rev Assoc Med Bras (1992). 2013, 59:161-6. 10.1016\/j.ramb.2012.11.004","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/ced.13030","article-title":"Piperacillin-tazobactam-induced linear IgA bullous dermatosis presenting clinically as Stevens-Johnson syndrome\/toxic epidermal necrolysis overlap","volume":"42","author":"Adler NR","year":"2017","unstructured":"Adler NR, McLean CA, Aung AK, Goh MS. Piperacillin-tazobactam-induced linear IgA bullous dermatosis presenting clinically as Stevens-Johnson syndrome\/toxic epidermal necrolysis overlap. Clin Exp Dermatol. 2017, 42:299-302. 10.1111\/ced.13030","journal-title":"Clin Exp Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2018.30.5.588","article-title":"Piperacillin-tazobactam-induced linear  IgA bullous dermatosis supported by a T-cell activation assay","volume":"30","author":"Ho YH","year":"2018","unstructured":"Ho YH, Chiu YW, Liu HN. Piperacillin-tazobactam-induced linear  IgA bullous dermatosis supported by a T-cell activation assay. Ann Dermatol. 2018, 30:588-91. 10.5021\/ad.2018.30.5.588","journal-title":"Ann Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/269210-heparin-induced-hemorrhagic-bullous-dermatosis-a-rare-complication-of-unfractionated-heparin","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T15:48:59Z","timestamp":1719935339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/269210-heparin-induced-hemorrhagic-bullous-dermatosis-a-rare-complication-of-unfractionated-heparin"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,2]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.63676","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,2]]}}}